drugset / Trial / NCT06854042
A Study of Oral E1018 in Healthy Adult Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.
Timeline
- Start
- 2025-02-26
- Primary completion
- 2025-12-23
- Completion
- 2025-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | E1018 | Unknown | — | Oral |